{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T07:45:59Z","timestamp":1723362359553},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,24]]},"DOI":"10.7759\/cureus.10635","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T16:18:25Z","timestamp":1600964305000},"source":"Crossref","is-referenced-by-count":5,"title":["The Genetic Foundations of Serotonin Syndrome, Neuroleptic Malignant Syndrome, and Malignant Hyperthermia: Is There a Genetic Association Between These Disorders?"],"prefix":"10.7759","author":[{"given":"Juan Fernando","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha","family":"Eskander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jazmin Carolina","family":"Cozar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olumuyiwa","family":"Fatade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bindu","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199819010-00006","article-title":"Neuroleptic malignant syndrome. Recognition, prevention and management","volume":"19","author":"Velamoor VR","year":"1998","unstructured":"Velamoor VR. Neuroleptic malignant syndrome. Recognition, prevention and management. Drug Safety. 1998, 19:73-82. 10.2165\/00002018-199819010-00006","journal-title":"Drug Safety"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/1941875210386491","article-title":"Neuroleptic malignant syndrome: a review for neurohospitalists","volume":"1","author":"Berman BD","year":"2011","unstructured":"Berman BD. Neuroleptic malignant syndrome: a review for neurohospitalists. Neurohospitalist. 2011, 1:41-47. 10.1177\/1941875210386491","journal-title":"Neurohospitalist"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"11","author":"Boyer EW","year":"2005","unstructured":"Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005, 11:1112-1120. 10.1056\/NEJMra041867","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-8948-1_49","article-title":"Serotonin Syndrome","author":"Gayle JA","year":"2015","unstructured":"Gayle JA, Abadie JV, Kaye AM, Kaye AD. Serotonin Syndrome. Essentials of pharmacology for anesthesia, pain medicine, and critical care. 2015, 797-807. 10.1007\/978-1-4614-8948-1_49","journal-title":"Essentials of pharmacology for anesthesia, pain medicine, and critical care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.158.6.850","article-title":"Is the predisposition to neuroleptic malignant syndrome genetically transmitted?","volume":"158","author":"Otani K","year":"1991","unstructured":"Otani K, Horiuchi M, Kondo T, Kaneko S, Fukushima Y. Is the predisposition to neuroleptic malignant syndrome genetically transmitted?. Br J Psychiatry. 1991, 158:850-853. 10.1192\/bjp.158.6.850","journal-title":"Br J Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.10.1714","article-title":"Association of the TaqI A polymorphism of the dopamine D2 receptor gene with predisposition to neuroleptic malignant syndrome","volume":"10","author":"Suzuki A","year":"2001","unstructured":"Suzuki A, Kondo T, Otani K, et al.. Association of the TaqI A polymorphism of the dopamine D2 receptor gene with predisposition to neuroleptic malignant syndrome. Am J Psychiatry. 2001, 10:1714-1716. 10.1176\/appi.ajp.158.10.1714","journal-title":"Am J Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.10025","article-title":"Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome","volume":"117B","author":"Mihara K","year":"2003","unstructured":"Mihara K, Kondo T, Suzuki A, et al.. Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome. Am J Med Genetics. 2003, 117B:57-60. 10.1002\/ajmg.b.10025","journal-title":"Am J Med Genetics"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.10.1830","article-title":"Pharmacogenetics of antidepressant medication intolerance","volume":"10","author":"Murphy GM","year":"2003","unstructured":"Murphy GM, Kremer C, Rodrigues HE, Schatzberg AF. Pharmacogenetics of antidepressant medication intolerance. Am J Psychiatry. 2003, 10:1830-1835. 10.1176\/appi.ajp.160.10.1830","journal-title":"Am J Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2008.00598.x","article-title":"Serotonin syndrome and the T102-->C polymorphism of the 5-HT2A receptor: a case report","volume":"10","author":"Lattanzi L","year":"2008","unstructured":"Lattanzi L, Danesi R, Lastella M, et al.. Serotonin syndrome and the T102-->C polymorphism of the 5-HT2A receptor: a case report. Bipolar Disord. 2008, 10:655-656. 10.1111\/j.1399-5618.2008.00598.x","journal-title":"Bipolar Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2013.47","article-title":"Serotonin toxicity from antidepressant overdose and its association with the t102c polymorphism of the 5-ht2a receptor","volume":"14","author":"Cooper J","year":"2014","unstructured":"Cooper J, Newby D, Whyte I, Carter G, Jones A, Isbister G. Serotonin toxicity from antidepressant overdose and its association with the t102c polymorphism of the 5-ht2a receptor. Pharm J. 2014, 14:390-394. 10.1038\/tpj.2013.47","journal-title":"Pharm J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835a11ba","article-title":"Serotonin syndrome following drug-drug interactions and cyp2d6 and cyp2c19 genetic polymorphisms in an HIV-infected patient","volume":"26","author":"Lorenzini KI","year":"2012","unstructured":"Lorenzini KI, Calmy A, Ambrosioni J, et al.. Serotonin syndrome following drug-drug interactions and cyp2d6 and cyp2c19 genetic polymorphisms in an HIV-infected patient. AIDS. 2012, 26:2417-2418. 10.1097\/QAD.0b013e32835a11ba","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145701002723","article-title":"Serotonin syndrome\u2014\u2018potential\u2019 role of the cyp2d6 genetic polymorphism in asians","volume":"5","author":"Kaneda Y","year":"2002","unstructured":"Kaneda Y, Kawamura I, Fujii A, Ohmori T. Serotonin syndrome\u2014\u2018potential\u2019 role of the cyp2d6 genetic polymorphism in asians. Int J Neuropsychopharmacol. 2002, 5:105-106. 10.1017\/S1461145701002723","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.15406\/jig.2017.04.00054","article-title":"Serotonin toxicity and cytochrome p450 poor metaboliser genotype patient case","volume":"4","author":"Piatkov I","year":"2017","unstructured":"Piatkov I, Mann G, Jones T, McLean M, Gunja N. Serotonin toxicity and cytochrome p450 poor metaboliser genotype patient case. J Investigative Genom. 2017, 4:1-5. 10.15406\/jig.2017.04.00054","journal-title":"J Investigative Genom"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3182a8a8e7","article-title":"Using exome data to identify malignant hyperthermia susceptibility mutations","volume":"5","author":"Gonsalves SG","year":"2013","unstructured":"Gonsalves SG, Ng D, Johnston JJ, et al.. Using exome data to identify malignant hyperthermia susceptibility mutations. Anesthesiology. 2013, 5:1043-1053. 10.1097\/ALN.0b013e3182a8a8e7","journal-title":"Anesthesiology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X1504300204","article-title":"Analysis of the entire ryanodine receptor type 1 and alpha 1 subunit of the dihydropyridine receptor (CACNA1S) coding regions for variants associated with malignant hyperthermia in Australian families","volume":"43","author":"Gillies RL","year":"2015","unstructured":"Gillies RL, Bjorksten AR, Du Sart D, Hockey BM. Analysis of the entire ryanodine receptor type 1 and alpha 1 subunit of the dihydropyridine receptor (CACNA1S) coding regions for variants associated with malignant hyperthermia in Australian families.  Anaesth Intensive Care. 2015, 43:157-166. 10.1177\/0310057X1504300204","journal-title":"Anaesth Intensive Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1800490115","article-title":"Junctional membrane Ca2+ dynamics in human muscle fibers are altered by malignant hyperthermia causative RyR mutation","volume":"115","author":"Cully TR","year":"2018","unstructured":"Cully TR, Choi RH, Bjorksten AR, Stephenson DG, Murphy RM, Launikonis BS\r\n. Junctional membrane Ca2+ dynamics in human muscle fibers are altered by malignant hyperthermia causative RyR mutation. Proc Natl Acad Sci. 2018, 115:8215-8220. 10.1073\/pnas.1800490115","journal-title":"Proc Natl Acad Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-8","article-title":"Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study","volume":"9","author":"Klingler W","year":"2014","unstructured":"Klingler W, Heiderich S, Girard T, et al.. Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study. Orphanet J Rare Dis. 2014, 9:8. 10.1186\/1750-1172-9-8","journal-title":"Orphanet J Rare Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/40989-the-genetic-foundations-of-serotonin-syndrome-neuroleptic-malignant-syndrome-and-malignant-hyperthermia-is-there-a-genetic-association-between-these-disorders","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:23:40Z","timestamp":1707506620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/40989-the-genetic-foundations-of-serotonin-syndrome-neuroleptic-malignant-syndrome-and-malignant-hyperthermia-is-there-a-genetic-association-between-these-disorders"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.10635","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,24]]}}}